GlobalData on MSN3d
FDA grants priority review for Boehringer’s zongertinib NDA in NSCLC
Priority review illustrates the urgent need in this patient population and the possibility for zongertinib to be a groundbreaking innovation for patients with limited treatment ...
News Medical3d
Novel classification system for SJS/TEN aims to improve patient care
First identified by Stevens and Johnson in 1922, SJS and TEN are now recognized as disorders with a continuum of severity, ...
Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company ...
The Scientist6d
Synthetic T Cells Provide Precision Immunosuppression
Scientists engineered T cells to protect instead of kill, potentially enabling targeted treatments for autoimmune disease and ...